Our team is developing a novel pentavalent, bispecific Nanobody for the treatment of asthma and other “Type 2” inflammatory diseases.
Base: $178,500.00 - $257,833.33; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified